Kenneth Michael Meyers

Title: **Kenneth Michael Meyers: Innovator in Pharmaceutical Chemistry**

Introduction

Kenneth Michael Meyers is a noted inventor based in Seymour, Connecticut, whose contributions to pharmaceutical chemistry have led to the development of several innovative compounds. With a total of four patents to his name, Meyers has focused on creating pharmaceutical solutions for critical health issues, particularly in the treatment of renal, cardiovascular, and fibrotic diseases.

Latest Patents

Among Meyers' latest patents is the development of bicyclic imidazole derivatives useful for the treatment of renal diseases, cardiovascular diseases, and fibrotic diseases. This invention pertains to compounds of a specific formula and includes their pharmaceutically acceptable salts. The patent delineates methods for utilizing these compounds in therapeutic applications and outlines processes for their preparation, including intermediates useful in these processes.

Another significant patent by Meyers involves aldosterone synthase inhibitors. This invention similarly pertains to compounds of a defined formula, associated with their pharmaceutically acceptable salts. It includes discussions on pharmaceutical compositions containing these compounds, methods of treatment for various diseases and disorders, and preparation processes that contribute to the overall efficiency and efficacy of the therapeutic agents.

Career Highlights

Kenneth Michael Meyers is currently employed with Boehringer Ingelheim International GmbH, where he collaborates with a talented team of researchers and scientists. His work is at the forefront of pharmaceutical innovation, pushing the boundaries of medical science to discover new avenues for treatment.

Collaborations

Meyers actively collaborates with other experts in the field, including notable coworkers Derek Cogan and Keith R Hornberger. These collaborations are essential as they foster a creative and scientifically rich environment, leading to advancements in drug discovery and development.

Conclusion

Kenneth Michael Meyers exemplifies the spirit of innovation in pharmaceutical research. With a strong track record of patents that address significant health challenges, he continues to contribute to the field while working alongside distinguished colleagues at Boehringer Ingelheim. His inventions not only demonstrate his expertise but also offer hope for effective treatments for diseases affecting countless individuals worldwide.